| Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial K Brady, T Pearlstein, GM Asnis, D Baker, B Rothbaum, CR Sikes, ... Jama 283 (14), 1837-1844, 2000 | 1023 | 2000 |
| Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder JRT Davidson, BO Rothbaum, BA van der Kolk, CR Sikes, GM Farfel Archives of general psychiatry 58 (5), 485-492, 2001 | 669 | 2001 |
| Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. MJ Friedman, CR Marmar, DG Baker, CR Sikes, GM Farfel Journal of Clinical Psychiatry 68 (5), 711-720, 2007 | 346 | 2007 |
| Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study J Davidson, T Pearlstein, P Londborg, KT Brady, B Rothbaum, J Bell, ... American Journal of Psychiatry 158 (12), 1974-1981, 2001 | 345 | 2001 |
| Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial L Lagae, J Sullivan, K Knupp, L Laux, T Polster, M Nikanorova, ... The Lancet 394 (10216), 2243-2254, 2019 | 293 | 2019 |
| Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment E Schweizer J Clin Psychiatry 62 (5), 325-331, 2001 | 227 | 2001 |
| Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial R Nabbout, A Mistry, S Zuberi, N Villeneuve, A Gil-Nagel, ... JAMA neurology 77 (3), 300-308, 2020 | 209 | 2020 |
| Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3, 4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. GM Farfel, LS Seiden Journal of Pharmacology and Experimental Therapeutics 272 (2), 860-867, 1995 | 144 | 1995 |
| Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey GM Farfel, MS Kleven, WL Woolverton, LS Seiden, BD Perry Brain research 578 (1-2), 235-243, 1992 | 137 | 1992 |
| Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and … GM Farfel, LS Seiden Journal of Pharmacology and Experimental Therapeutics 272 (2), 868-875, 1995 | 112 | 1995 |
| Characterizing the effects of sertraline in post-traumatic stress disorder JRT Davidson, LR Landerman, GM Farfel, CM Clary Psychological medicine 32 (4), 661-670, 2002 | 90 | 2002 |
| The N-methyl-d-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine 3, 4-methylenedioxymethamphetamine and p-chloroamphetamine GM Farfel, GL Vosmer, LS Seiden Brain research 595 (1), 121-127, 1992 | 85 | 1992 |
| Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies SG Kornstein, TB Pearlstein, R Fayyad, GM Farfel, JA Gillespie Journal of Clinical Psychiatry 67 (10), 1624, 2006 | 80 | 2006 |
| Fenfluramine acts as a positive modulator of sigma-1 receptors P Martin, PAM de Witte, T Maurice, A Gammaitoni, G Farfel, B Galer Epilepsy & Behavior 105, 106989, 2020 | 78 | 2020 |
| A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of … B Boyd, S Smith, A Gammaitoni, BS Galer, GM Farfel International Journal of Clinical Pharmacology and Therapeutics 57 (1), 11, 2019 | 61 | 2019 |
| Efficacy and safety of fenfluramine for the treatment of seizures associated with Lennox-Gastaut syndrome: a randomized clinical trial KG Knupp, IE Scheffer, B Ceulemans, JE Sullivan, KC Nickels, L Lagae, ... JAMA neurology 79 (6), 554-564, 2022 | 58 | 2022 |
| Fenfluramine HCl (Fintepla®) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study J Sullivan, IE Scheffer, L Lagae, R Nabbout, M Pringsheim, D Talwar, ... Epilepsia 61 (11), 2396-2404, 2020 | 56 | 2020 |
| A randomized controlled trial of ganaxolone in posttraumatic stress disorder AM Rasmusson, CE Marx, S Jain, GM Farfel, J Tsai, X Sun, TD Geracioti, ... Psychopharmacology 234, 2245-2257, 2017 | 49 | 2017 |
| Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: analysis of an ongoing long‐term open‐label safety extension study WW Lai, BS Galer, PC Wong, G Farfel, M Pringsheim, MG Keane, ... Epilepsia 61 (11), 2386-2395, 2020 | 46 | 2020 |
| Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young … KI Bishop, PK Isquith, GA Gioia, AR Gammaitoni, G Farfel, BS Galer, ... Epilepsy & Behavior 121, 108024, 2021 | 44 | 2021 |
